Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

China · Delayed Price · Currency is CNY

9.26

-0.01 (-0.11%)

Feb 27, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Leasing and Property Services Industry	28.40M	27.65M	22.44M	31.08M	-
Leasing and Property Services Industry Growth	2.74%	23.19%	-27.80%	-	-
Pharmaceutical R&D and Consistency Assessment	203.58M	191.82M	183.77M	140.14M	-
Pharmaceutical R&D and Consistency Assessment Growth	6.13%	4.38%	31.14%	-	-
Clinical Trial	148.95M	142.63M	135.89M	106.70M	-
Clinical Trial Growth	4.43%	4.96%	27.35%	-	-
Other Income	2.54M	4.12M	4.27M	205.58K	-
Other Income Growth	-38.27%	-3.44%	1976.54%	-	-
Total	383.47M	366.22M	346.37M	278.13M	-
Total Growth	4.71%	5.73%	24.54%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	383.47M	-	-	-	-
Total	383.47M	-	-	-	-

Source: S&P Global Market Intelligence.